Ikarian Capital, LLC 13D and 13G filings for Quoin Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-06 5:28 pm Unchanged | 2026-01-31 | 13G | Quoin Pharmaceuticals, Ltd. QNRX | Ikarian Capital, LLC | 211,538 12.600% | 0 (Unchanged) | Filing |
| 2025-12-15 9:53 pm Purchase | 2025-11-30 | 13G | Quoin Pharmaceuticals, Ltd. QNRX | Ikarian Capital, LLC | 211,538 25.200% | 211,538 (New Position) | Filing |